This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
QUICK READ: Reaching physicians with key brand messages isn’t hard, but the online landscape has become crowded with many players. By far, Medscape is still number one in physician reach , and medical journal advertising has been proven to result in more branded Rx’s. million physicians worldwide, in multiple languages.
Tik-Tok, Instagram, and other social media channels may soon be overwhelmed with pharma companies’ content, but is it a good idea? According to MedData Group, 72% of physicians surveyed were active on Facebook weekly, and 38% were active on Instagram and LinkedIn weekly. ” The post Can pharma really leverage social media?
Zoom Rx recently polled HCPs and found 78% of physicians want to maintain some contact with pharma reps. The most desired information doctors now want is about patient assistance programs, with 49% saying they want pharma reps to provide that information. 1ne: Medscape – Still number one with physicians.
IN BRIEF: Pharma companies have been posting jobs on LinkedIn almost every day. While most offices remain closed pharma is preparing for the launch of new products and has to have the infrastructure to ensure a successful launch. This is a great time for people who want to be the change they want to see to work in pharma.
Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives.
Unlike consumer brands that can use aggressive bidding strategies on high-volume keywords, pharma ads must navigate strict regulatory guidelines. For an in-depth look at how pharma companies succeed in digital advertising, visit Pharma Marketing Network. Understanding Pharma-Specific PPC Challenges 1.
SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. They research the drug online and ask their physician about it if they decide it’s a treatment option.
Can pharma leverage influencer marketing? People are turning to their favorite Instagram stars, Twitter personalities, and YouTubers for advice and recommendations on purchasing decisions, but does this apply to prescription drugs? Influencers have already been talking about pharma. The post Influencer marketing in pharma.
In addition to immediate access to a physician, they offer on-site labs to analyze blood, MRI and CAT scan machines, pharmacies, and a full range of OTC products. It’s frustrating to wait for an MRI and wait again for another appointment with a physician to go over the results. Where does pharma fit in?
In the world of pharma marketing, the strategies that truly resonate are often those rooted in trust. But how does referral marketing work in a highly regulated industry like pharma? This article explores the evolving role of referral marketing in pharma, unpacking its mechanics, benefits, compliance considerations, and future outlook.
SUMMARY: The biggest threat to the pharma industry isn’t the coming tsunami of healthcare changes. The content was sponsored by the brand but was written by leading cancer physicians with titles like “how to manage your cancer therapies” and “what to tell your Oncologist.” Brand awareness skyrocketed.
This is just another example of how clueless the FDA is regarding patient behavior and prescription drugs. Some patients love the brand of prescription drugs they take because simply “they work” Pharma companies do study brand names, but that’s only about the overall branding of the product.
Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. Nowhere is this clearer than in pharma DTC TV ads. A Prevention Magazine study dated had prescription DTC ads as being 7% effective in driving new Rx’s. ” Ninety-two percent of U.S.
Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. But how can pharma marketers break through the noise, engage their audience, and see real ROI? Drive prescription intent by educating HCPs about the latest drug advancements.
Trust, for example, in physicians is still relatively high. Most patients completely trusted their physicians “to put their needs above all other considerations” (69%). Physician trust in the U.S. Physician trust in the U.S. Even patients will still line up if a prescription drug shows promise.
What is the definition of a successful pharma product launch? Pharma companies have been investing deeply into digital advertising but vastly under measuring customer engagement and other metrics. Work with vendors to submit quantitative metrics proposals, like reaching a certain percentage of your targeted physicians.
1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. People don’t want to lose weight through diet and exercise if they can lose it through a prescription drug.
SUMMARY: Today, more physicians and patients rely on the Internet to answer their questions about emerging treatments, including prescription drugs. If there is one industry that needs to think more about digital, it’s pharma. This is a severe concern in an era where more HCPs are refusing to meet with pharma reps.
Digital pharma marketers have to “sell” the organization on the promise of digital marketing, but they also need to communicate that along with successes, there could be many failures. To master digital marketing, pharma needs to be prepared to fail. After the detail, the physician rated the interaction as “excellent.”
Artificial intelligence is revolutionizing how pharma brands engage with healthcare professionals (HCPs) and patients, optimizing advertising campaigns, and improving customer experiences. As competition in the healthcare space intensifies, pharma brands that fail to integrate AI risk falling behind.
Introduction In an era dominated by digital marketing, traditional advertising remains a vital tool for pharma companies to connect with healthcare professionals (HCPs) and patients alike. Lets explore how traditional advertising can deliver powerful results for pharma marketing teams. Trust and familiarity.
This comes at a time when industry fart sniffing publications like Fierce Pharma report “pharma continues to shine under the pandemic spotlight. Pharma earned a solid No. BMS believes they price our medicines based on the value they deliver,” but physicians say the price is too high. FOLLOW PROFIT, NOT NEED.
In conjunction with CMI Media Group’s international expansion beyond the United States, we conducted research and published a report in partnership with Medscape which delved into the media habits of physicians across the EU5 countries: France, Germany, Italy, Spain, and the United Kingdom.
Fourteen percent of US consumers reported lapses in access to or taking their prescription medications. More than three-quarters of physicians say their practice is offering telemedicine visits. Digital channels play a far greater role in communication between pharma companies and healthcare professionals than before the pandemic. .
Among the 26% of respondents who talked to a health care provider about a specific prescription drug they saw advertised, 16% said they received a prescription for the advertised drug. Online research is used to evaluate new prescription drugs. But is this really true across all DTC? Is TV the best channel?
Definition: A prescription is a written order for a patient to receive a medication or treatment. It is typically written by a physician or other authorized healthcare provider and given to the patient, who then takes it to a pharmacy to have it filled.
Social media advertising now plays a crucial role in reaching healthcare professionals (HCPs) and patients , allowing pharma brands to engage, educate, and build trust like never before. But heres the challenge: strict industry regulations make social media advertising tricky for pharma marketers.
Once vaccination levels reach critical mass, people will once again return to their physician’s offices. Let’s be clear about pharma product websites. Most are OK with telehealth but don’t want patients using telehealth to ask for new prescriptions. Having just a website is not enough.
Despite a slew of prescription options and widespread advertising pushes, most patients are sticking with over-the-counter (OTC) remedies rather than trying new preventive medications, according to Phreesia Life Sciences’ survey results collected from more than 4,000 patients checking in for their doctors’ appointments in July 2021.
Pity the poor pharma brand marketer. Should pharma brand campaigns drive quality, affinity, or persuasion? Survey Reveals Why Brand Building Matters Two big themes emerge that distinguish pharma marketing. First, pharma categories are dominated by the top 20% of prescribers. Brand-building campaigns!
Survey any physician if they’ve been asked by a patient about a prescription weight loss medication and you’ll hear a resounding “yes.” The recent Sermo Barometer confirms that 89% of 300+ global practitioners have seen an increase in patients proactively requesting prescription weight loss medications.
Researchers found that physicians don’t think very highly of health insurance companies and believe they’re putting patients at risk with policies such as prior authorizations ahead of filling prescriptions. Health insurance policies are stressing many physicians out. Health and the piggy bank.
Typically, results or new treatment prescriptions are simply uploaded to the portal with the doctors expected to give explanations during the appointment—even though the ability to provide additional information within the portal is readily available. However, only 32% of patients trust pharma-developed apps.
Value-based healthcare is a healthcare delivery model in which providers, including hospitals and physicians, are paid based on patient health outcomes. Prescription drugs costs are just a small part of healthcare costs (11%). This has to be upsetting to employers experiencing riding employee healthcare costs.
Pharma websites provide the prescription that can help people overcome health problems but too often, they ignore the patient’s responsibility to lose weight and exercise. The FDA should require every pharma product website to devote part of its content to prevention and the importance of exercise.
How is pharma going to get patients back into to ask their doctor about branded medications? Health spending for the calendar year may end up lower than it was in 2019 but spending on prescription drugs has not fallen which could be due to price increases. Year-to-date spending on health services is down about 2% from last year.
Social media is part of our online lives, but too many people believe what they read regarding health information and prescription drugs. NOBODY goes to a pharma website and says “I’m going to ask for that drug!” Pharma websites need to evolve.
Besides, physicians have still not bought into the whole technology trends unless it drives patients into their office. What I’m not seeing is the need for improved basic patient contact points with pharma, especially in the digital area. The technology is more about wellness, then helping patients monitor their health.
All prescription drugs don’t make us healthy; they just mask a potentially unhealthy lifestyle that eventually will cost patients and our healthcare system a lot of money, time, and pain. Where does pharma’s responsibility in this area? Pharma companies too often see themselves as just a business that provides a product.
Below is a Q&A with Mark Bard, Co-Founder of The DHC Group, who offers his insights on the challenges COVID-19 has brought to pharma, as well as what innovation is taking place due to this full shift to digital and what lies ahead in the future. How does the situation impact pharma? Does that mean they have no access?
Our healthcare system makes too much money for insurers, PBM’s and pharma companies to change. There’s evidence that patients will embrace transparency in the form of accessing their physicians’ notes about them, based on the OpenNotes project which showed higher engagement in patients that had access to HCP’s notes.
The inability to “pull through” a prescription, despite healthcare provider (HCP) field team engagement and educational efforts, stubbornly remains a top client concern after 15 years of working in the market access space. My Uncle Scott has a rare disease that affects less than 1% of his physician’s patient population.
Traditionally, when pharma marketers and their strategy, creative, and media agencies develop marketing plans, investment recommendations tend to focus on HCPs, patients, and managed care. Pharma marketers have begun to respond to this shift by allocating more of their promotional budgets to the NP/PA community.
Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available to patients and provides access to COVID-19 therapeutics that may otherwise be difficult to obtain. “We are currently focused on offering a convenient way to get prescriptions. The platform.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content